GlaxoSmithKline eyes further acquisitions
Wednesday 22 October 2008
GlaxoSmithKline, the UK’s biggest drugs group, is set to embark on a programme of acquisitions as increased competition from generic rivals, and falling sales of its established treatments, has put pressure on the group’s traditional markets.
The chief executive Andrew Witty, who was appointed in May and has since announced a change of tack that will see GSK attempt to expand its consumer healthcare and emerging markets operations, added that the group had undergone a “tough transition period” in the last year.
Despite the cautionary tone of Mr Witty’s comments, the market reacted positively to the group’s third quarter results published today. While net profits dropped 21.6 per cent to £1.03bn, GSK’s shares closed the day up 1.3 per cent at 1143p. The group showed a 7 per cent increase in sales to £5.88bn and a 6 per cent hike in earnings-per-share to 25.2p. The divided was increased from 1p to 14p, which analysts at Charles Stanley said would be warmly received by the market.
GSK has already been active in the buyout market, having announced earlier this week that it has paid $170m for Biotene, a dry mouth mouthwash, from privately owned Laclede. The deal comes less than a week after the Brentford-based group spent $210m on Bristol Myers Squibb’s mature pharmaceutical products in Egypt, giving it licence options across the Middle East.
The move into areas such as Egypt comes as GSK faces increased competition from generics firms, which are increasingly challenging the research led groups’ patents, particularly in the United States. GSK’s biggest selling product, diabetes treatment Avandia continued to suffer a fall in sales. The drug has suffered a 40 per cent slide in sales since May last year, when the New England Medical Journal published a report linking Avandia to greater risk of heart attacks.
- 1 Amy Winehouse statue unveiled in Camden
- 2 Lego breaks out of the toy box and heads for the gallery
- 3 George Galloway on Scottish independence: The political class is doing what Hitler couldn’t – destroying Britain
- 4 Headaches, fry ups, and hair of the dog - why do we get hangovers, and is there such thing as a 'cure'?
- 5 A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
George Galloway on Scottish independence: The political class is doing what Hitler couldn’t – destroying Britain
Daniele Watts: Django Unchained actress detained in Los Angeles after being mistaken for a prostitute
Scottish independence: Nationalist leader Jim Sillars threatens pro-union companies with 'day of reckoning' after independence
Scottish independence: Yes campaign feels the heat as Alex Salmond's NHS claims come under furious attack
Scottish independence: Britain faces 'constitutional crisis' at next election
£23m Birmingham cycle scheme is attacked by Tory councillor for not catering to the elderly
iJobs Money & Business
£280 - £320 per day: Ashdown Group: The Ashdown Group have been engaged by a l...
£400 - £450 Per Day: Clearwater People Solutions Ltd: **URGENT CONTRACT ROLE**...
£35000 - £38000 per annum + Benefits: Ashdown Group: Training Coordinator / Pl...
Data Governance Manager (Solvency II) – Contract – Up to £450 daily rate, 6 month (may go Permanent)
£400 - £450 Per Day: Clearwater People Solutions Ltd: We are currently looking...